Spirulina vs Chlorella — algae compared honestly
Both are blue-green algae with marketing that wildly outpaces the trial evidence. Spirulina has a slightly stronger case for blood pressure and lipid modulation in meta-analysis; chlorella's marquee claim is "detoxification," which the evidence does not robustly support outside specific occupational toxin scenarios. Neither is a credible B12 source for vegans despite ubiquitous claims. Heavy-metal contamination is the bigger practical issue than which species "wins" on benefits.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Blood pressure (mildly elevated) | Spirulina | Meta-analyses show ~4–5 mmHg systolic reduction at 1–8 g/day across trials. |
| Lipid panel (total cholesterol, LDL, triglycerides) | Spirulina (modest) | Meta-analyses show modest LDL and TG reductions; effect size small. |
| "Detoxification" / heavy metal binding | Chlorella (very limited) | Chlorella cell wall binds methylmercury in animal models and occupational case series; benefit in everyday "detox" is hype. |
| Allergic rhinitis | Spirulina (small RCTs) | Small trials show histamine-related symptom reduction at 2 g/day; modest evidence. |
| B12 source for vegans | Neither — use a real B12 supplement | Both contain B12 analogs (pseudo-B12) that are not bioavailable as B12. |
| Contamination risk profile | Chlorella (slightly cleaner average) | Both can carry heavy metals or microcystins from contaminated growing waters; brand-level testing matters more than species. |
How they actually work
Spirulina (Arthrospira platensis) — phycocyanin and gamma-linolenic acid
Spirulina is technically a cyanobacterium (blue-green prokaryote) rather than a true alga. The most-studied bioactive is phycocyanin, a blue protein-pigment with antioxidant and anti-inflammatory activity. Spirulina contains 60–70% protein by dry weight, gamma-linolenic acid (GLA), and a range of carotenoids. Meta-analyses of clinical trials in adults with elevated blood pressure or dyslipidemia show modest improvements at 1–8 g/day over 8–12 weeks.
Chlorella (Chlorella vulgaris, C. pyrenoidosa) — eukaryotic single-celled algae
Chlorella is a true green alga with a tough cellulose cell wall that must be broken to liberate intracellular nutrients (look for "cracked cell wall" on the label). The "detoxification" claim hinges on the cell wall's ability to bind lipophilic toxicants (PCBs, dioxins, mercury) in the gut and reduce enterohepatic recirculation. There is animal-model and limited occupational human evidence for this with specific exposures; the everyday "detox" framing in consumer marketing is not supported by clinical outcome data.
Blood pressure and lipids
Spirulina meta-analyses (Huang 2018, Mohiti 2021) show roughly 4–5 mmHg systolic and 2–3 mmHg diastolic blood pressure reductions at typical supplement doses. LDL reductions of 10–20 mg/dL and triglyceride reductions of 20–40 mg/dL are reported in pooled analyses. Effect sizes are modest and not lifestyle-replacement. Chlorella has smaller meta-analyses with similar direction-of-effect for lipids but less consistent.
The B12 myth
Both algae are routinely marketed as plant sources of B12, particularly for vegans. The B12 in spirulina and chlorella is predominantly pseudo-B12 (cobamides that are not biologically active in humans) — and worse, they can occupy intrinsic factor receptors and competitively reduce absorption of real B12. Functional vitamin B12 status studies in vegans using spirulina or chlorella as their B12 source show inadequate repletion. Use a methylcobalamin or cyanocobalamin supplement, not algae, for vegan B12.
The contamination question
Both algae bioconcentrate trace elements from their growing water. Spirulina can be contaminated with microcystins (cyanotoxins from co-cultured Microcystis), heavy metals (lead, mercury, cadmium), and PCBs. Chlorella has similar risks. Independent testing varies — ConsumerLab and Labdoor reports periodically show products failing on contaminants. Pick brands with third-party heavy metal and microcystin testing; brand matters more than species.
The autoimmune cautions
Both algae appear to upregulate certain immune pathways. Case reports and pharmacovigilance data describe flares of autoimmune conditions (notably systemic lupus, multiple sclerosis-like exacerbations) attributed to algae supplements. Direction of causation is uncertain but the signal is consistent enough that users with active autoimmune disease should be cautious or avoid.
Dose, form, and timing
Spirulina: 1–8 g/day; powder, tablet, or capsule. Take with food to reduce GI side effects.
Chlorella: 2–6 g/day; insist on cracked or broken cell wall. Powder, tablet, capsule.
Safety
Both algae are generally well-tolerated. GI upset, transient green stool (chlorella), and photosensitivity (rare) are reported. The phenylalanine content of spirulina is relevant in phenylketonuria — avoid. Microcystin contamination from poorly-controlled growing operations is the most consequential safety issue and is brand-specific.
What we'd actually buy
For most adults: a third-party tested spirulina at 2–4 g/day is the marginally better-supported pick if you want to try this category for blood pressure or lipid support. Treat it as a small auxiliary — diet, exercise, sleep, and (when indicated) standard medications produce larger effects. For vegans needing B12: methylcobalamin or cyanocobalamin, not algae.
Sources
- Huang H, et al. The effects of spirulina supplementation on serum lipid profile, glycemic control, and inflammatory factors. Front Nutr. 2022;9:850993. PMID: 35464033
- Mohiti S, et al. Spirulina supplementation and oxidative stress markers and inflammation: a systematic review and meta-analysis. Clin Nutr ESPEN. 2021;42:74–81. PMID: 33745625
- Watanabe F, et al. Pseudovitamin B(12) is the predominant cobamide of an algal health food, spirulina tablets. J Agric Food Chem. 1999;47(11):4736–4741. PMID: 10552882
- Merino JJ, et al. The effects of chlorella supplementation on cardiovascular risk factors: a systematic review. Curr Pharm Des. 2018;24(34):4032–4041. PMID: 30317993
- Karkos PD, et al. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2011;2011:531053. PMID: 19299804
- Roy-Lachapelle A, et al. Microcystins in dietary supplements containing cyanobacteria, the case of spirulina. Toxins (Basel). 2017;9(3):76. PMID: 28245621